Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)
Clinical trial NCT00637845 · COMPLETED
Trial details
- NCT number
- NCT00637845
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-06-01
- Primary completion
- 2003-02-01
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.